The House of Commons Health and Social Care Committee will be holding an evidence session in October on the impact of a no-deal Brexit on health and social care. The session will be an opportunity for the Committee to follow up its earlier reports, ‘Brexit and health and social care: people’ and process and ‘Brexit: medicines, medical devices and substances of human origin’.
The committee is inviting written submissions from all interested parties, setting out:
- What the impact of a no-deal Brexit* is likely to be on their sector of the health and social care system (whether that be patients, suppliers to the health and social care system, providers of NHS or social care services, NHS or social care staff, or others).
- Specifically, what the risks are to patients and to the health and social care system of leaving the European Union without a withdrawal agreement. The Committee would be particularly pleased to hear from patient representative groups about the extent of the potential risk to patient care of any disruption to the supply from the EU-27 to the UK of medicines, medical devices or substances of human origin.
- How effectively stakeholders are planning for the possibility of a no-deal Brexit.
- How effectively they consider the Government is planning for such an outcome.
- What further planning, or reassurances, are required in order to ensure that the impact of a no-deal Brexit on health and social care would be minimised.
*The committee defines a “no-deal Brexit” as withdrawal from the European Union with neither a Withdrawal Agreement (under article 50.2 of the Treaty on European Union), nor an agreement on the future relationship between the UK and the EU. Further detail can be found on the European Union Brexit preparedness webpages and on the website of the UK Department for Exiting the European Union.
If you would like to contribute to a Together for Short Lives submission, please email email@example.com